Literature DB >> 28937574

Committee Opinion No. 722: Marijuana Use During Pregnancy and Lactation.

.   

Abstract

Cannabis sativa (marijuana) is the illicit drug most commonly used during pregnancy. The self-reported prevalence of marijuana use during pregnancy ranges from 2% to 5% in most studies. A growing number of states are legalizing marijuana for medicinal or recreational purposes, and its use by pregnant women could increase even further as a result. Because of concerns regarding impaired neurodevelopment, as well as maternal and fetal exposure to the adverse effects of smoking, women who are pregnant or contemplating pregnancy should be encouraged to discontinue marijuana use. Obstetrician-gynecologists should be discouraged from prescribing or suggesting the use of marijuana for medicinal purposes during preconception, pregnancy, and lactation. Pregnant women or women contemplating pregnancy should be encouraged to discontinue use of marijuana for medicinal purposes in favor of an alternative therapy for which there are better pregnancy-specific safety data. There are insufficient data to evaluate the effects of marijuana use on infants during lactation and breastfeeding, and in the absence of such data, marijuana use is discouraged.

Entities:  

Mesh:

Year:  2017        PMID: 28937574     DOI: 10.1097/AOG.0000000000002354

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  57 in total

1.  Maternal persistent marijuana use and cigarette smoking are independently associated with shorter gestational age.

Authors:  Nobutoshi Nawa; Henri M Garrison-Desany; Yoona Kim; Yuelong Ji; Xiumei Hong; Guoying Wang; Colleen Pearson; Barry S Zuckerman; Xiaobin Wang; Pamela J Surkan
Journal:  Paediatr Perinat Epidemiol       Date:  2020-06-30       Impact factor: 3.980

2.  Prenatal Marijuana Use by Self-Report and Umbilical Cord Sampling in a State With Marijuana Legalization.

Authors:  Torri D Metz; Robert M Silver; Gwendolyn A McMillin; Amanda A Allshouse; Triniti L Jensen; Chanel Mansfield; Kennon Heard; Gregory L Kinney; Erica Wymore; Ingrid A Binswanger
Journal:  Obstet Gynecol       Date:  2019-01       Impact factor: 7.661

3.  Media portrayal of prenatal and postpartum marijuana use in an era of scientific uncertainty.

Authors:  Marian Jarlenski; Jonathan W Koma; Jennifer Zank; Lisa M Bodnar; Jill A Tarr; Judy C Chang
Journal:  Drug Alcohol Depend       Date:  2018-04-11       Impact factor: 4.492

4.  Self-reported Medical and Nonmedical Cannabis Use Among Pregnant Women in the United States.

Authors:  Nora D Volkow; Beth Han; Wilson M Compton; Elinore F McCance-Katz
Journal:  JAMA       Date:  2019-07-09       Impact factor: 56.272

5.  Trends in marijuana use among pregnant women with and without nausea and vomiting in pregnancy, 2009-2016.

Authors:  Kelly C Young-Wolff; Varada Sarovar; Lue-Yen Tucker; Lyndsay A Avalos; Stacey Alexeeff; Amy Conway; Mary Anne Armstrong; Constance Weisner; Cynthia I Campbell; Nancy Goler
Journal:  Drug Alcohol Depend       Date:  2019-01-18       Impact factor: 4.492

6.  Association of Nausea and Vomiting in Pregnancy With Prenatal Marijuana Use.

Authors:  Kelly C Young-Wolff; Varada Sarovar; Lue-Yen Tucker; Lyndsay A Avalos; Amy Conway; Mary Anne Armstrong; Nancy Goler
Journal:  JAMA Intern Med       Date:  2018-10-01       Impact factor: 21.873

Review 7.  Marijuana Use in Pregnancy and While Breastfeeding.

Authors:  Torri D Metz; Laura M Borgelt
Journal:  Obstet Gynecol       Date:  2018-11       Impact factor: 7.661

Review 8.  Cannabis use during pregnancy and postpartum.

Authors:  Sophia Badowski; Graeme Smith
Journal:  Can Fam Physician       Date:  2020-02       Impact factor: 3.275

9.  Data Are Needed on the Potential Adverse Effects of Marijuana Use in Pregnancy.

Authors:  Nancy Goler; Amy Conway; Kelly C Young-Wolff
Journal:  Ann Intern Med       Date:  2018-08-21       Impact factor: 25.391

Review 10.  [Position paper on medical cannabis and cannabis-based medicines in pain medicine].

Authors:  Frank Petzke; Matthias Karst; Knud Gastmeier; Lukas Radbruch; Eva Steffen; Winfried Häuser
Journal:  Schmerz       Date:  2019-10       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.